ESICM Guidelines on Fluid Therapy in Critically Ill Patients: The ROSE Concept
The European Society of Intensive Care Medicine (ESICM) recommends using balanced crystalloids as first-line fluid therapy for most critically ill patients, with specific considerations for different clinical scenarios based on the ROSE concept (Resuscitation, Optimization, Stabilization, Evacuation) of fluid management. 1
General Principles of Fluid Therapy
- ESICM guidelines emphasize that intravenous fluids should be considered as drugs, requiring careful selection based on patient condition, clinical scenario, and expected outcomes 2
- The ROSE concept provides a framework for fluid management through different phases of critical illness:
Choice of Resuscitation Fluids
Crystalloids vs. Colloids
ESICM conditionally recommends using crystalloids rather than albumin for volume expansion in:
- General critically ill patients (moderate certainty of evidence)
- Patients with sepsis (moderate certainty of evidence)
- Patients with acute respiratory failure (very low certainty of evidence)
- Perioperative patients and those at risk for bleeding (very low certainty of evidence) 1
Specific exceptions where albumin may be preferred:
Balanced vs. Non-balanced Crystalloids
ESICM conditionally recommends balanced crystalloids (e.g., Ringer's lactate, Plasma-Lyte) rather than isotonic saline (0.9% NaCl) in:
- General critically ill population (low certainty of evidence)
- Patients with sepsis (low certainty of evidence)
- Patients with kidney injury (very low certainty of evidence) 1
Exception: Isotonic saline is conditionally recommended over balanced crystalloids in patients with traumatic brain injury (very low certainty of evidence) 1
Hypertonic Solutions
- ESICM conditionally recommends against using small-volume hypertonic crystalloids for general fluid resuscitation in critically ill patients (very low certainty of evidence) 1
- This aligns with other guidelines that specifically recommend against using 3% or 7.5% hypertonic solutions as first-line treatment in hemorrhagic shock to reduce mortality (Grade 1- recommendation) 2
Fluid Administration Strategy
Initial fluid challenge should be at least 30 mL/kg of crystalloids in patients with sepsis-induced tissue hypoperfusion (Grade 1C) 2
Fluid challenges should follow a structured approach:
- Define type of fluid to be administered
- Rate and volume of infusion
- Endpoints to assess response
- Safety limits to prevent fluid overload 5
Dynamic tests of fluid responsiveness (when applicable) are preferred over static measurements:
Special Clinical Scenarios
Sepsis and Septic Shock
- Crystalloids are recommended as first-line fluid therapy 2, 1
- Balanced crystalloids are preferred over 0.9% NaCl to reduce mortality and adverse renal events 1
- Albumin may be considered in patients requiring substantial amounts of crystalloids 2
- Avoid hydroxyethyl starches due to increased risk of acute kidney injury and mortality 2
Hemorrhagic Shock
- Balanced crystalloids are probably recommended over 0.9% NaCl as first-line fluid therapy (Grade 2+ recommendation) 2
- Avoid albumin administration in most cases of hemorrhagic shock 2
- Hypertonic solutions (3% or 7.5%) are not recommended as first-line treatment 2
Traumatic Brain Injury
- Isotonic saline is conditionally recommended over balanced crystalloids 1
- Isotonic saline is conditionally recommended over albumin 1
Common Pitfalls in Fluid Management
- Failure to recognize the transition between phases of fluid therapy (resuscitation to de-escalation) 3
- Over-reliance on static measures of preload (CVP) which poorly predict fluid responsiveness 5
- Inadequate monitoring for signs of fluid overload during resuscitation 4
- Not considering the chloride content of fluids and potential impact on acid-base balance and kidney function 2, 6
- Continuing fluid administration despite lack of hemodynamic improvement from previous fluid challenges 5
By following the ROSE concept and these evidence-based recommendations, clinicians can optimize fluid therapy in critically ill patients while minimizing potential complications related to inappropriate fluid selection or volume.